Sep 17, 2026•3 min read
Professor Hong Highlights Gaps in Pricing Reform for Chronic Disease Innovative Drugs
Despite focus on rare disease and oncology, Korea's drug price reform still limits innovative treatments for common chronic conditions, says Seoul National University economist.